<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05098769</url>
  </required_header>
  <id_info>
    <org_study_id>AOAPECT</org_study_id>
    <nct_id>NCT05098769</nct_id>
  </id_info>
  <brief_title>A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.</brief_title>
  <official_title>A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using Parameters Obtained by Computed Tomographic Pulmonary Angiography.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shengjing Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study collected clinical, laboratory, and CT parameters of acute patients with acute PE&#xD;
      from admission to predict adverse outcomes within 30 days after admission into hospital.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study collected clinical, laboratory, and CT parameters of acute patients with acute PE&#xD;
      from admission. The outcomes of interest were defined as the occurrence of adverse outcomes&#xD;
      within 30 days after admission into hospital.&#xD;
&#xD;
      Eligible patients were randomized in some ratio into derivation and validation cohorts. The&#xD;
      derivation cohort was used to develop and evaluate a multivariable logistic regression model&#xD;
      for predicting the outcomes of interest. The discriminatory power was evaluated by comparing&#xD;
      the nomogram to the established risk stratification systems. The consistency of the nomogram&#xD;
      was evaluated using the validation cohort.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Adeverse outcomes</measure>
    <time_frame>30 days</time_frame>
    <description>The outcomes of interest were defined as the occurrence of adverse outcomes within 30 days after admission. Adverse outcomes were defined as PE-related deaths, the need for mechanical ventilation, the need for cardiopulmonary resuscitation, and the need for life-saving vasopressor and reperfusion treatment.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pulmonary Embolism and Thrombosis</condition>
  <condition>Deterioration, Clinical</condition>
  <arm_group>
    <arm_group_label>Acute pulmonary embolism</arm_group_label>
    <description>an age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  reception of reperfusion treatment before admission&#xD;
&#xD;
          -  missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I),&#xD;
             and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>YIZHUO GAO</last_name>
    <phone>+86-18940257523</phone>
    <email>gaoyizhuo.sy@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shenjing Hospital of CHINA MEDICAL UNIVERSITY</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YIZHUO GAO</last_name>
      <phone>+86-18940257523</phone>
      <email>gaoyizhuo.sy@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 16, 2021</study_first_submitted>
  <study_first_submitted_qc>October 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shengjing Hospital</investigator_affiliation>
    <investigator_full_name>YIZHUO GAO</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pulmonary Embolism and Thrombosis</keyword>
  <keyword>Deterioration, Clinical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Embolism and Thrombosis</mesh_term>
    <mesh_term>Clinical Deterioration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

